Category: Fellowship
Victoria Shelus Studies Antimalarial Drug Use and Practice at Drug Shops in Uganda
Victoria Shelus studies antimalarial drug use and practice at drug shops in Uganda, building on the work of Dr. Ross Boyce. Victoria Shelus, a PhD candidate working with Dr. Ross Boyce, explores client and vendor health behavior and practice after a study confirmed more than half of all antimalarials administered in Uganda come from drug shops. In the remote villages of Bugoye su … Read more
Juliano Receives $3.4 million to Study the Increase of Relapsing Malaria Species in Africa
Jonathan Juliano, MD, MPSH, Professor of Infectious Diseases and Associate Director of the Institute for Global Health and Infectious Diseases, with fellow IDEEL investigators Jessica Lin, MD, MSCR, and Jonathan Parr, MD, MPH, and co-PIs from the University of Florida (UF) and Centre Pasteur Cameroon, has received a $3.4 million R01 grant award to study the changing epidemiology … Read more
Scientists Create Long-acting Injectable Drug Delivery System for Tuberculosis
Martina Kovarova, PhD In 2020, more than 1.5 million people around the world died of tuberculosis (TB), marking the first time in more than a decade that annual TB deaths had increased and demonstrating the global need for better access to treatments. To address that problem, scientists with the 黑料网 Department of Medicine, the 黑料网 Institute for Global Health and Infectious Diseas … Read more
Study shows the positive effect of preventative therapy for malaria is mediated by gestational weight gain, influenced by intestinal pathogens
Andreea Waltmann and the late Steve Meshnick. Malaria in pregnancy (MiP) is a major public health problem with substantial risks for mothers and their babies. The combination treatment sulfadoxine-pyrimethamine (SP), given for聽intermittent preventive therapy聽of malaria in pregnancy (IPTp), is one of the few existing interventions that improve outcomes for both mother and baby, de … Read more
CDC renews five-year funding for vector-borne disease threats
Ross Boyce, MD The Center for Disease Control and Prevention (CDC) has announced the five-year funding renewal of the Southeastern Center for Vector-Borne Diseases (SECVBD), an interdisciplinary team of researchers that includes 黑料网鈥檚 Ross Boyce, MD, MSc, a member of the 黑料网 Institute for Global Health & Infectious Diseases and assistant professor in infectious diseases and e … Read more
Rutstein Appointed to HIGH IRI Training Program
Sarah Rutstein, MD, PhD, a physician scientist and senior clinical fellow in the Division of Infectious Diseases in the Department of Medicine, has been accepted to the HIV Infectious Disease and Global Health Implementation Research Institute (HIGH IRI) through the Center for Dissemination and Implementation at the Institute for Public Health at Washington University in St. Loui … Read more
New Fellows Match to the Department of Medicine
The National Resident Matching Program released results for the 2021 Medical Specialties Matching Program (MSMP) on December 1. 聽It is the organization鈥檚 largest Fellowship Match comprised primarily of Internal Medicine subspecialties. This year the national聽program matched more than 7,000 applicants聽to advanced training positions, the largest number on record.聽The Department of … Read more
Welcome to our 2022-2023 ID fellows!
We are excited to announce that we have matched 4 physicians to the ID Fellowship for the 2022-2023 academic year! Drs. Briana Castillo, Alex Commanday, John Franzone, and Stephanie Sweitzer will be joining 黑料网 in July. Briana Castillo, MD Interests: HIV, HCV, LGBTQIA+ health, and substance use Residency: University of Illinois Chicago Alex Commanday, MD Interests: Domestic HIV i … Read more
Rutstein awarded NC TraCS pilot grant for characterizing long-acting injectable antiretroviral therapy
Sarah Rutstein, MD, PhD Third year ID fellow Sarah Rutstein, MD, PhD (co-I Farel, Go, Napravnik) was awarded a $50K pilot grant from the North Carolina Translational and Clinical Sciences Institute (NC TraCS). NC TraCS supports and funds translational research to improve the health of North Carolina communities. The institute鈥檚 Translational Research Matched Pilot Program encoura … Read more
Parr, Senior Author of Study That Shows Plasmodium Falciparum Evolving to Escape Malaria Rapid Diagnostics in Africa
Jonathan Parr, MD A major tool against malaria in Africa has been the use of rapid diagnostic tests, which have been part of the 鈥渢est-treat-track鈥� strategy in Ethiopia, the second most-populated country in Africa. But researchers studying blood samples from more than 12,000 individuals in Ethiopia now estimate these tests missed nearly 10% of malaria cases caused by the parasite … Read more
Novel CRISPR-Based Malaria Diagnostic Capable of Plasmodium Detection, Species Differentiation, and Drug-Resistance Genotyping
Jessica Lin, MD MSCR CRISPR-based diagnostics are a new class of highly sensitive and specific assays with multiple applications in infectious disease diagnosis. SHERLOCK, or Specific High-Sensitivity Enzymatic Reporter UnLOCKing, is one such CRISPR-based diagnostic that combines recombinase polymerase pre-amplification, CRISPR-RNA base-pairing, and LwCas13a activity for nucleic … Read more
Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics
Jonathan Parr, MD Jonathan Parr, MD, MPH, assistant professor in the division of infectious diseases, was interviewed for an article in The Scientist about the聽development of CRISPR diagnostics. Since the start of the COVID-19 pandemic, researchers have been striving to develop low-cost tests to detect the presence of SARS-CoV-2 in patient samples. Now, a team of researchers base … Read more